Finance

Lists
603567:SHA
Heilongjiang ZBD Pharmaceutical Co Ltd
5,04 CN¥
-1,95%
(-0,100) 1D
16 қаз., 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603567...
Open
5,17 CN¥
High
5,30 CN¥
Low
5,00 CN¥
Mkt. cap
4,83 млрд
Avg. vol.
23,25 млн
Volume
25,29 млн
52-wk high
12,14 CN¥
52-wk low
4,21 CN¥
EPS
-1,53 CN¥
Shares outstanding
849,16 млн
No. of employees
2 мың
Open
5,17 CN¥
High
5,30 CN¥
Low
5,00 CN¥
Mkt. cap
4,83 млрд
Avg. vol.
23,25 млн
Volume
25,29 млн
52-wk high
12,14 CN¥
52-wk low
4,21 CN¥
EPS
-1,53 CN¥
Shares outstanding
849,16 млн
No. of employees
2 мың
News stories
From web sources and news partners
About Heilongjiang ZBD Pharmaceutical Co Ltd
CEO-
Employees1,96 мың
Founded1996 ж. 28 қаз.
Headquarters-
SectorPharmaceutical industry
Websitezbdzy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
204,78 млн
-120,85 млн
181,56 млн
113,79 млн
Cost of goods sold
206,91 млн
600,55 млн
180,99 млн
54,52 млн
Cost of revenue
206,91 млн
600,55 млн
180,99 млн
54,52 млн
Research and development expenses
8,75 млн
26,82 млн
8,64 млн
-3,48 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
99,80 млн
43,54 млн
71,31 млн
74,02 млн
Operating expense
137,83 млн
225,64 млн
209,39 млн
120,96 млн
Total operating expenses
344,75 млн
826,18 млн
390,38 млн
175,48 млн
Operating income
-139,97 млн
-947,03 млн
-208,82 млн
-61,69 млн
Other non operating income
12,87 млн
-374,29 млн
-102,60 м.
10,46 млн
EBT including unusual items
-350,54 млн
-1,16 млрд
-226,54 млн
-100,48 млн
EBT excluding unusual items
-168,80 млн
-1,31 млрд
-241,63 млн
-74,50 млн
Income tax expense
-55,10 млн
-168,17 млн
-45,60 млн
-11,32 млн
Effective tax rate
15,72%
14,47%
20,13%
11,27%
Other operating expenses
-34,39 млн
40,92 млн
7,96 млн
8,89 млн
Net income
-294,81 млн
-993,43 млн
-179,95 млн
-91,03 млн
Net profit margin
-143,97%
822,03%
-99,11%
-79,99%
Earnings per share
-
-
-
-
Interest and investment income
137,59 м.
31,21 млн
104,31 м.
88,56 мың
Interest expense
-41,82 млн
-24,43 млн
-30,57 млн
-25,61 млн
Net interest expenses
-41,69 млн
6,78 млн
-30,46 млн
-25,52 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-101,46 млн
-905,32 млн
-167,10 млн
-20,49 млн
Gain or loss from assets sale
-
612,90 м.
-
-
AI content may include mistakes. Learn more
Google қолданбалары